These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21289259)

  • 1. Increased transactivation associated with SOX3 polyalanine tract deletion in a patient with hypopituitarism.
    Alatzoglou KS; Kelberman D; Cowell CT; Palmer R; Arnhold IJ; Melo ME; Schnabel D; Grueters A; Dattani MT
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E685-90. PubMed ID: 21289259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mutation in SOX3 polyalanine tract: a case of Kabuki syndrome with combined pituitary hormone deficiency harboring double mutations in MLL2 and SOX3.
    Takagi M; Ishii T; Torii C; Kosaki K; Hasegawa T
    Pituitary; 2014 Dec; 17(6):569-74. PubMed ID: 24346842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX3 deletion in mouse and human is associated with persistence of the craniopharyngeal canal.
    Alatzoglou KS; Azriyanti A; Rogers N; Ryan F; Curry N; Noakes C; Bignell P; Hall GW; Littooij AS; Saunders D; Thomas P; Stewart H; Dattani MT
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2702-8. PubMed ID: 25140394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism.
    Woods KS; Cundall M; Turton J; Rizotti K; Mehta A; Palmer R; Wong J; Chong WK; Al-Zyoud M; El-Ali M; Otonkoski T; Martinez-Barbera JP; Thomas PQ; Robinson IC; Lovell-Badge R; Woodward KJ; Dattani MT
    Am J Hum Genet; 2005 May; 76(5):833-49. PubMed ID: 15800844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyalanine expansion mutations in the X-linked hypopituitarism gene SOX3 result in aggresome formation and impaired transactivation.
    Wong J; Farlie P; Holbert S; Lockhart P; Thomas PQ
    Front Biosci; 2007 Jan; 12():2085-95. PubMed ID: 17127446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased transactivation and impaired repression of β-catenin-mediated transcription associated with a novel SOX3 missense mutation in an X-linked hypopituitarism pedigree with modest growth failure.
    Yu T; Chang G; Cheng Q; Yao R; Li J; Xu Y; Li G; Ding Y; Qing Y; Li N; Shen Y; Wang X; Wang J
    Mol Cell Endocrinol; 2018 Dec; 478():133-140. PubMed ID: 30125608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xq27.1 Duplication Encompassing SOX3: Variable Phenotype and Smallest Duplication Associated with Hypopituitarism to Date - A Large Case Series of Unrelated Patients and a Literature Review.
    Arya VB; Chawla G; Nambisan AKR; Muhi-Iddin N; Vamvakiti E; Ajzensztejn M; Hulse T; Ferreira Pinto C; Lahiri N; Bint S; Buchanan CR; Kapoor RR
    Horm Res Paediatr; 2019; 92(6):382-389. PubMed ID: 31678974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked phenotypic variable expression among brothers with duplication of Xq27.1 involving the SOX3 gene.
    Rosolowsky ET; Stein R; Marks SD; Leonard N
    J Pediatr Endocrinol Metab; 2020 Mar; 33(3):443-447. PubMed ID: 26352083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic Variants in Established Hypopituitarism Genes Expand Our Knowledge of the Phenotypic Spectrum.
    Nakaguma M; Ferreira NGBP; Benedetti AFF; Madi MC; Silva JM; Li JZ; Ma Q; Bilge Ozel A; Fang Q; Narcizo AM; Cardoso LC; Montenegro LR; Funari MFA; Nishi MY; Arnhold IJP; Jorge AAL; Mendonca BB; Camper SA; Carvalho LR
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital hypopituitarism in two brothers with a duplication of the 'acrogigantism gene' GPR101: clinical findings and review of the literature.
    Elizabeth MSM; Verkerk AJMH; Hokken-Koelega ACS; Verlouw JAM; Argente J; Pfaeffle R; Neggers SJCMM; Visser JA; de Graaff LCG
    Pituitary; 2021 Apr; 24(2):229-241. PubMed ID: 33184694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide copy number analysis and systematic mutation screening in 58 patients with hypogonadotropic hypogonadism.
    Izumi Y; Suzuki E; Kanzaki S; Yatsuga S; Kinjo S; Igarashi M; Maruyama T; Sano S; Horikawa R; Sato N; Nakabayashi K; Hata K; Umezawa A; Ogata T; Yoshimura Y; Fukami M
    Fertil Steril; 2014 Oct; 102(4):1130-1136.e3. PubMed ID: 25064402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xq26.3-q27.1 duplication including SOX3 gene in a Chinese boy with hypopituitarism: case report and two years treatment follow up.
    Du C; Wang F; Li Z; Zhang M; Yu X; Liang Y; Luo X
    BMC Med Genomics; 2022 Feb; 15(1):19. PubMed ID: 35114986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic insight into the pathology of polyalanine expansion disorders revealed by a mouse model for X linked hypopituitarism.
    Hughes J; Piltz S; Rogers N; McAninch D; Rowley L; Thomas P
    PLoS Genet; 2013; 9(3):e1003290. PubMed ID: 23505376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A complex phenotype in a family with a pathogenic SOX3 missense variant.
    Jelsig AM; Diness BR; Kreiborg S; Main KM; Larsen VA; Hove H
    Eur J Med Genet; 2018 Mar; 61(3):168-172. PubMed ID: 29175558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3.
    Solomon NM; Ross SA; Morgan T; Belsky JL; Hol FA; Karnes PS; Hopwood NJ; Myers SE; Tan AS; Warne GL; Forrest SM; Thomas PQ
    J Med Genet; 2004 Sep; 41(9):669-78. PubMed ID: 15342697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for increased SOX3 dosage as a risk factor for X-linked hypopituitarism and neural tube defects.
    Bauters M; Frints SG; Van Esch H; Spruijt L; Baldewijns MM; de Die-Smulders CE; Fryns JP; Marynen P; Froyen G
    Am J Med Genet A; 2014 Aug; 164A(8):1947-52. PubMed ID: 24737742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-linked isolated growth hormone deficiency: expanding the phenotypic spectrum of SOX3 polyalanine tract expansions.
    Burkitt Wright EM; Perveen R; Clayton PE; Hall CM; Costa T; Procter AM; Giblin CA; Donnai D; Black GC
    Clin Dysmorphol; 2009 Oct; 18(4):218-21. PubMed ID: 19654509
    [No Abstract]   [Full Text] [Related]  

  • 18. Congenital hypopituitarism: clinical, molecular and neuroradiological correlates.
    Mehta A; Hindmarsh PC; Mehta H; Turton JP; Russell-Eggitt I; Taylor D; Chong WK; Dattani MT
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):376-82. PubMed ID: 19320653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperphagia, mild developmental delay but apparently no structural brain anomalies in a boy without SOX3 expression.
    Helle JR; Barøy T; Misceo D; Braaten Ø; Fannemel M; Frengen E
    Am J Med Genet A; 2013 May; 161A(5):1137-42. PubMed ID: 23463539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD).
    Turton JP; Mehta A; Raza J; Woods KS; Tiulpakov A; Cassar J; Chong K; Thomas PQ; Eunice M; Ammini AC; Bouloux PM; Starzyk J; Hindmarsh PC; Dattani MT
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):10-8. PubMed ID: 15963055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.